UNQUOTE

Sabadell Asabys et al. lead €14m series-E for MedLumics

  • LinkedIn  
  • Google plus  

Sabadell Asabys, VI Partners and CDTI Innvierte have led a €14m series-E round for Spanish healthcare device startup MedLumics.

Previous backers Andera Partners, Caixa Capital Risc and Innogest Capital also took part in the funding round.

Previous funding
In December 2011, Spanish venture capital firm Ysios Capital Partners led a €3.5m series-A for MedLumics alongside Caixa Capital Risc.

A venture capital syndicate led by Edmond de Rothschild Investment Partners (EdRip) invested €34.4m in the business in March 2017. Italian GP Innogest and Ireland-based Seroba Life Sciences participated, alongside an undisclosed strategic investor, while previous backers Ysios and Caixa Capital Risc also provided financing.

As part of the deal, EdRip partner Olivier Litzka and his peers Claudio Rumazza from Innogest and James Green from Seroba joined the company's board of directors.

Company 
Founded in 2009 and headquartered in Madrid, MedLumics develops cardiac-related medical devices. The company's flagship product is the AblaView catheter, focused on the treatment of atrial fibrillation and other arrhythmias.

People
MedLumics – James Greene (CEO).
Asabys Partners – Josep Sanfeliu (managing partner).

  • LinkedIn  
  • Google plus  

More on Early-stage

Latest News